SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-20-007870
Filing Date
2020-01-15
Accepted
2020-01-15 12:38:32
Documents
1
Effectiveness Date
2020-01-15

Document Format Files

Seq Description Document Type Size
1 S-8 POS d850713ds8pos.htm S-8 POS 20156
  Complete submission text file 0001193125-20-007870.txt   21183
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-231400 | Film No.: 20527840
SIC: 2836 Biological Products, (No Diagnostic Substances)